−Removed: Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
+Added: Unregistered Sales of Equity Securities and Use of Proceeds
Share Issuance Program
In February 2021, the Company filed a $150.0 million shelf registration statement and $50.0 million prospectus supplement with the SEC under which it may offer and sell, from time to time, up to $50.0 million worth of its common stock in "at-the-market" offerings.
−Removed: During the three months ended September 30, 2023, the Company did not issue shares under the prospectus supplement.
−Removed: On September 30, 2023, $11.6 million remains under the prospectus supplement, which equates to 16.5 million shares based on the share price as of September 30, 2023.
+Added: During the six months ended December 31, 2023, the Company did not issue shares under the prospectus supplement.
+Added: On December 31, 2023, $11.6 million remains under the prospectus supplement, which equates to 1.2 million shares based on the share price as of December 31, 2023.
+Added: The program expires on February 10, 2024.
Share Repurchase Program
In May 2000, the Board approved a stock repurchase program with no stated expiration date.
−Removed: Since that time and through September 30, 2023, the Board has authorized $650.0 million to be expended for the repurchase of the Company's stock under this program.
+Added: Since that time and through December 31, 2023, the Board has authorized $650.0 million to be expended for the repurchase of the Company's stock under this program.
All repurchased shares become authorized but unissued shares of the Company.
The Company last purchased shares in fiscal year 2020.
−Removed: As of September 30, 2023, a total accumulated 30.0 million shares have been repurchased for $595.4 million.
−Removed: At September 30, 2023, $54.6 million remains outstanding under the approved stock repurchase program.
+Added: As of December 31, 2023, a total accumulated 1.5 million shares have been repurchased for $595.4 million.
+Added: At December 31, 2023, $54.6 million remains outstanding under the approved stock repurchase program.
The Company does not expect to repurchase shares in fiscal year 2024.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.